BofA/Merrill Opens MGLN With Buy

by Lisa Levin, Benzinga Editor

April 11, 2011 6:45 AM | 13 seconds read | Make a Comment

Analysts at BofA/Merrill initiate coverage of Magellan Health Services Inc

MGLN

with a “buy” rating. The target price for MGLN is set to $50. MGLN shares gained 0.14% to close at $49.83 on Friday.

Posted In: Initiation Analyst Ratings Bofa/Merrill Health Care Managed Health Care

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.